Hati-Cancer is developing new drugs for metastatic cancer targeted therapy.
Description
Hati-Cancer is developing new drugs for metastatic cancer targeted therapy. The company was composed of 4 founders: Bruno Azevedo (CEO), Miguel Sousa (CTO), Ricardo Soares (COO), Rodrigo Pires (CCO), who are all Electrical Engineers.